Fact Sheet for Healthcare Providers: Gnomegen COVID-19 RT-qPCR Detection Kit – Gnomegen, LLC

Source: U.S. Food and Drug Administration (FDA). Published: 5/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Gnomegen COVID-19 RT-qPCR Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on May 8, 2020. The Gnomegen COVID-19 RT-qPCR Detection Kit is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news